Henrike Lucas Selected Research

1-methylimidazole

12/2021

Imidazole Analogs of Vascular-Disrupting Combretastatin A-4 with Pleiotropic Efficacy against Resistant Colorectal Cancer Models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Henrike Lucas Research Topics

Disease

7	Neoplasms (Cancer) 08/2023 - 01/2016
3	Colorectal Neoplasms (Colorectal Cancer) 08/2023 - 08/2019
1	Neoplasm Metastasis (Metastasis) 12/2021
1	Colonic Neoplasms (Colon Cancer) 09/2021
1	Shock 01/2020
1	Carcinoma (Carcinomatosis) 11/2016

Drug/Important Bio-Agent (IBA)

3	PolymersIBA 08/2020 - 01/2016
3	hydroxypropyl methacrylateIBA 08/2020 - 01/2016
1	LuciferasesIBA 08/2023
1	Alkenes (Olefins)IBA 12/2021
1	1-methylimidazoleIBA 12/2021
1	imidazoleIBA 12/2021
1	fosbretabulin (combretastatin A4)IBA 12/2021
1	TubulinIBA 12/2021
1	brimaminIBA 12/2021
1	HydrogelsIBA 09/2021
1	Small Interfering RNA (siRNA)IBA 09/2021
1	IceIBA 01/2020
1	SolventsIBA 01/2020
1	Angiopoietin-2IBA 08/2019
1	AntibodiesIBA 08/2019
1	Bevacizumab (Avastin)FDA Link 08/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2019
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2018
1	Betulinic AcidIBA 11/2016
1	N-(2-hydroxypropyl)methacrylamideIBA 11/2016
1	Cytostatic AgentsIBA 11/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 12/2021 - 01/2016
2	Therapeutics 08/2019 - 01/2016